SCHEMBL21323946

SCHEMBL21323946

O=C1c2cccc3c2c(cc2ccccc23)C1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.47
HSD17B10 Q99714 4/20 0.47
HPGD P15428 4/20 0.47
MAPK1 P28482 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
HIF1A Q16665 2/20 0.47
CASP1 P29466 2/20 0.47
TSHR P16473 1/20 0.47
CES1 P23141 1/20 0.41
MAPT P10636 4/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
KDM4E B2RXH2 3/20 0.40
CYP1A2 P05177 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP3A4 P08684 2/20 0.40
TP53 P04637 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13654079 0.88 HPRT1 (0.40) ALDH1A1HSD17B10HPGDMAPK1L3MBTL1
SCHEMBL24276180 0.81 RAB9A (0.37) ALDH1A1L3MBTL1MEN1KMT2AKDM4E
SCHEMBL6880786 0.75 ALDH1A1 (0.45) ALDH1A1HSD17B10HPGDMAPK1L3MBTL1
SCHEMBL21699094 0.73 CYP1B1 (0.43) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL12726414 0.73 ALDH1A1 (0.56) ALDH1A1HSD17B10HPGDMAPK1L3MBTL1
SCHEMBL20698681 0.73 ALDH1A1 (0.42) ALDH1A1HSD17B10HPGDMAPK1L3MBTL1
SCHEMBL11222343 0.70 KDM4E (0.39) ALDH1A1HSD17B10HPGDMAPK1CES1
SCHEMBL23049948 0.69 CYP1B1 (0.42) ALDH1A1L3MBTL1MAPTMEN1KMT2A
SCHEMBL15906510 0.68 CYP2D6 (0.47) ALDH1A1HSD17B10MAPK1MAPTMEN1
SCHEMBL1627194 0.68 ALDH1A1 (0.68) ALDH1A1HSD17B10HPGDMAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220081378-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2022-03-17 US disclosed
EP-2200104-B1 Organic light-emitting device CANON KK (JP) 2019-09-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220081378-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CCNL2, ORC3, OR51E2 ALDH1A1 1723/4885HSD17B10 3282/4885HPGD 4196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.